Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Jones

Showing results (451-460 of 490) with videos related to

Pageof 49
Sort By:
The Lancet. Psychiatry|March 14, 2026
Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model studyBenjamin I Perry, Emanuele F Osimo, Shuqing Si, et al.
PLOS Mental Health|February 9, 2026
Age-at-migration, ethnicity and psychosis risk: Findings from the EU-GEI case-control studyHumma Andleeb, Bettina Moltrecht, Charlotte Gayer-Anderson, et al.
The Lancet Regional Health. Europe|August 30, 2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samplesBenjamin I Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample setsMichael Chen-Xu, Ruth Topless, Cushla McKinney, et al.
Schizophrenia Bulletin|May 4, 2026
Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI StudyCraig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, et al.
Acta Psychiatrica Scandinavica|November 1, 2024
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI studyGiuseppe D'Andrea, Diego Quattrone, Giada Tripoli, et al.
The Lancet. Psychiatry|March 24, 2019
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control studyMarta Di Forti, Diego Quattrone, Tom P Freeman, et al.
Social Psychiatry and Psychiatric Epidemiology|January 25, 2020
The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control ProgrammeCharlotte Gayer-Anderson, Hannah E Jongsma, Marta Di Forti, et al.
Journal of Clinical Medicine|July 26, 2019
Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control StudySupriya Misra, Bizu Gelaye, Karestan C Koenen, et al.
Psychological Medicine|January 25, 2022
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI studyVictoria Rodriguez, Luis Alameda, Diego Quattrone, et al.
Pageof 49

Showing results (451-460 of 490) with videos related to

Sort By:
Pageof 49
The Lancet. Psychiatry|March 14, 2026
Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model studyBenjamin I Perry, Emanuele F Osimo, Shuqing Si, et al.
PLOS Mental Health|February 9, 2026
Age-at-migration, ethnicity and psychosis risk: Findings from the EU-GEI case-control studyHumma Andleeb, Bettina Moltrecht, Charlotte Gayer-Anderson, et al.
The Lancet Regional Health. Europe|August 30, 2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samplesBenjamin I Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample setsMichael Chen-Xu, Ruth Topless, Cushla McKinney, et al.
Schizophrenia Bulletin|May 4, 2026
Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI StudyCraig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, et al.
Acta Psychiatrica Scandinavica|November 1, 2024
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI studyGiuseppe D'Andrea, Diego Quattrone, Giada Tripoli, et al.
The Lancet. Psychiatry|March 24, 2019
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control studyMarta Di Forti, Diego Quattrone, Tom P Freeman, et al.
Social Psychiatry and Psychiatric Epidemiology|January 25, 2020
The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control ProgrammeCharlotte Gayer-Anderson, Hannah E Jongsma, Marta Di Forti, et al.
Journal of Clinical Medicine|July 26, 2019
Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control StudySupriya Misra, Bizu Gelaye, Karestan C Koenen, et al.
Psychological Medicine|January 25, 2022
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI studyVictoria Rodriguez, Luis Alameda, Diego Quattrone, et al.
Pageof 49